Manganese Deficiency

Manganese deficiency represents a significant but often underrecognized nutritional disorder affecting farm animals across multiple species including cattle, sheep, goats, pigs, and poultry. This trace mineral serves essential functions in enzyme systems, skeletal development, reproductive function, and carbohydrate metabolism, making adequate manganese nutrition critical for optimal animal health and productivity. Unlike some mineral deficiencies that produce dramatic acute symptoms, manganese insufficiency typically manifests through subtle, chronic problems that can significantly impact production efficiency without obvious clinical signs. The insidious nature of this deficiency means it often goes undiagnosed while quietly reducing herd profitability through impaired reproduction, poor growth, and skeletal abnormalities.

The condition affects virtually all farm animal species, though the manifestations and severity vary considerably between species and production stages. Cattle and other ruminants develop manganese deficiency when dietary intake is insufficient or when excessive dietary calcium, phosphorus, or iron interfere with manganese absorption. Poultry are particularly sensitive to manganese inadequacy, developing characteristic skeletal deformities including perosis, or slipped tendon, that cause significant welfare and economic concerns. Pigs deficient in manganese show reproductive failure and skeletal abnormalities. Sheep and goats grazing manganese-deficient soils exhibit poor reproduction and growth performance. The prevalence of true deficiency varies by geographic region, with areas of naturally manganese-poor soils or intensive cropping practices depleting soil manganese being most affected.

The economic impact of manganese deficiency extends across multiple aspects of livestock production, making it a condition of considerable importance to farm profitability. Reproductive losses including delayed puberty, irregular estrous cycles, poor conception rates, and increased embryonic mortality can devastate breeding programs in both commercial and purebred operations. Growth performance suffers in deficient animals, reducing feed efficiency and extending time to market weight. Skeletal abnormalities may cause lameness and soundness issues that affect both productivity and animal welfare. In poultry operations, manganese deficiency causes eggshell quality problems and reduced hatchability that directly impact economic returns. Subclinical deficiency, which may be more common than recognized, causes subtle production losses that accumulate over time.

Early detection and prevention of manganese deficiency are essential because many of the consequences, particularly skeletal deformities and certain reproductive impacts, are irreversible once they occur. Recognition of risk factors, appropriate diagnostic testing, and implementation of effective supplementation programs allow producers to prevent deficiency before economic and welfare impacts occur. The condition responds well to proper supplementation when addressed in a timely manner, though correcting skeletal abnormalities in growing animals or reversing reproductive damage is not possible. Understanding manganese nutrition and its interactions with other dietary components enables producers and nutritionists to develop feeding programs that ensure adequate manganese status throughout the production cycle.

The primary cause of manganese deficiency in farm animals is insufficient dietary intake of available manganese, which can result from multiple factors related to soil conditions, forage composition, and feeding practices. Soils naturally low in manganese produce forages and grains with inadequate manganese content, creating the foundation for deficiency in grazing animals and those fed locally produced feeds. Intensive agricultural practices that remove crops without returning organic matter can deplete soil manganese over time. High soil pH, which occurs naturally in limestone regions or results from excessive liming, reduces manganese availability to plants even when total soil manganese is adequate. Sandy soils with low organic matter content are particularly prone to manganese deficiency due to poor mineral retention.

Dietary interactions significantly influence manganese availability and can induce deficiency even when total dietary manganese appears adequate. Excessive dietary calcium is a major contributor to manganese deficiency, as calcium competes with manganese for absorption sites in the intestinal tract. High-calcium diets fed to dairy cattle or laying hens for production purposes can paradoxically create manganese deficiency. Iron at high dietary concentrations similarly interferes with manganese absorption. Phosphorus interactions with manganese are complex and may reduce availability under certain circumstances. High-grain diets, which are common in intensive production systems, tend to be lower in manganese than forage-based diets and may contribute to deficiency in feedlot cattle, confined dairy herds, and intensively raised pigs.

Species-specific factors influence manganese requirements and susceptibility to deficiency across different farm animals. Poultry have relatively high manganese requirements compared to other species, making them more susceptible to deficiency when dietary supply is marginal. The developing embryo and rapidly growing chick have particularly high demands for manganese in bone and cartilage formation. Breeding animals across all species have elevated requirements to support gamete development, embryonic survival, and fetal growth. Lactating animals lose manganese in milk and must replace this through dietary intake. Young, rapidly growing animals of all species have higher requirements per unit of body weight than mature animals.

Environmental and management factors contribute to manganese deficiency risk on individual farms. Geographic location determines baseline soil manganese levels and influences the mineral content of locally produced feeds. Water sources with high mineral content, particularly high calcium or iron, may reduce manganese absorption. Housing systems that prevent soil contact eliminate any contribution from incidental soil ingestion, which may provide trace minerals including manganese in outdoor systems. Intensive production practices that maximize growth rate or production output increase metabolic demands for manganese. Failure to include manganese in mineral supplementation programs, or providing supplements with inadequate manganese levels, allows deficiency to develop in animals at risk.

The pathophysiology of manganese deficiency relates to the essential roles this trace mineral plays in multiple enzyme systems and metabolic processes. Manganese serves as a cofactor for enzymes involved in cartilage synthesis, making it critical for normal skeletal development. The manganese-dependent enzyme pyruvate carboxylase is essential for gluconeogenesis and energy metabolism. Manganese is required for normal mitochondrial function and protection against oxidative damage through its role in manganese-superoxide dismutase. Reproductive function depends on manganese through pathways involving steroid hormone synthesis and sperm development. When dietary manganese is insufficient to support these functions, the clinical manifestations of deficiency develop progressively.

Early warning signs of manganese deficiency are typically subtle and nonspecific, making recognition challenging without systematic monitoring of production parameters. Reduced growth rates in young animals may be the first indication of inadequate manganese nutrition, though this sign could result from numerous other nutritional or health issues. Slight decreases in feed efficiency, where animals require more feed to achieve expected gains, may indicate subclinical deficiency. Roughened or dull hair coats in cattle and sheep sometimes accompany manganese deficiency. Poultry may show slightly reduced growth and poor feathering in early deficiency. Reproductive performance that falls below expected levels, including conception rates slightly lower than normal, can indicate emerging deficiency before more obvious signs appear.

Skeletal abnormalities represent the most characteristic and recognizable manifestation of manganese deficiency, particularly in growing animals. In calves born to manganese-deficient dams or becoming deficient during the rapid growth phase, limb deformities including enlarged joints, twisted legs, and abnormal bone development may be observed. These skeletal changes result from impaired cartilage synthesis during bone development. In poultry, perosis or slipped tendon is the classic sign of manganese deficiency, characterized by enlargement of the hock joint, twisting of the distal tibiotarsus and tarsometatarsus, and slippage of the gastrocnemius tendon from its normal position. Affected chicks and poults are unable to walk normally and may become completely crippled. Pigs deficient in manganese develop crooked or shortened legs, enlarged joints, and lameness.

Reproductive failure is a major consequence of manganese deficiency that significantly impacts breeding programs across species. In cattle, deficient females may exhibit delayed puberty, irregular or absent estrous cycles, poor conception rates, and increased early embryonic mortality. Bulls with manganese deficiency may have reduced libido and produce semen with lower sperm counts and increased abnormal sperm morphology. In pigs, reproductive signs include irregular estrus, reduced litter size, and increased stillbirths and weak-born piglets. Poultry experience reduced egg production, poor eggshell quality, and dramatically decreased hatchability with increased embryonic mortality during incubation. The characteristic sign in incubating eggs from manganese-deficient hens is chondrodystrophy, a condition where embryos develop shortened and deformed legs.

Behavioral and neurological changes may accompany manganese deficiency, though these are less commonly recognized than skeletal and reproductive manifestations. Newborn calves from severely deficient dams may show weakness, poor coordination, and difficulty standing and nursing. Some deficient animals display increased nervousness or excitability, possibly related to altered neurotransmitter metabolism. Convulsions have been reported in severely deficient newborns of several species. General weakness and lethargy may be observed in animals with chronic, severe deficiency affecting energy metabolism through impaired gluconeogenesis.

Progression of manganese deficiency follows a predictable pattern as tissue stores become depleted and metabolic dysfunction advances. Initial depletion of tissue manganese occurs without obvious clinical signs, representing the subclinical phase where production efficiency may already be compromised. As deficiency becomes more severe, reproductive parameters decline, growth rates slow, and skeletal abnormalities begin developing in growing animals. Prolonged severe deficiency results in the full spectrum of clinical manifestations including obvious skeletal deformities, complete reproductive failure, and potential neurological involvement.

Emergency symptoms requiring immediate intervention are less common with manganese deficiency than with some other mineral disorders, given its chronic, progressive nature. However, newborn animals with severe congenital skeletal deformities may require euthanasia on welfare grounds if the defects prevent standing and nursing. Severely affected poultry with complete perosis causing inability to reach food and water need immediate intervention. Cases where multiple animals in a group simultaneously show skeletal abnormalities should trigger urgent diagnostic workup and diet reformulation. Any situation where reproduction in a breeding group has essentially ceased warrants immediate investigation including manganese status evaluation.

Clinical examination provides initial clues to manganese deficiency but cannot definitively confirm the diagnosis due to the nonspecific nature of many signs. The veterinarian will evaluate growth performance, body condition, and skeletal conformation while gathering detailed history about diet, supplementation, and production parameters. Characteristic skeletal abnormalities in young animals or poultry strongly suggest manganese involvement. Poor reproductive performance in a group of animals receiving apparently adequate nutrition should prompt consideration of trace mineral deficiencies including manganese. Physical examination may reveal enlarged joints, limb deformities, poor hair coat quality, and general unthriftiness that support suspicion of mineral deficiency.

Laboratory testing for manganese status involves several approaches, each with advantages and limitations. Blood or serum manganese concentrations can be measured, though interpretation is challenging because blood levels are maintained within a relatively narrow range even when tissue stores are depleted. Normal serum manganese concentrations do not rule out deficiency at the tissue level. Liver manganese concentrations provide a more reliable assessment of status but require biopsy samples, limiting practicality for routine monitoring. Bone manganese content reflects long-term status but requires sample collection through biopsy or at slaughter. Hair or wool manganese analysis has been evaluated but shows variable correlation with status. In poultry, measuring manganese in egg yolk or eggshell can indicate dietary supply and hen status.

Differential diagnosis must consider other conditions that produce similar clinical presentations. Skeletal abnormalities resembling manganese deficiency can result from other nutritional deficiencies including copper, zinc, and vitamin D, as well as genetic conditions and infectious diseases affecting bone development. Reproductive failure has numerous potential causes including infectious diseases, other nutritional deficiencies, toxicities, and management factors. Poor growth performance is a nonspecific sign with many possible explanations. In poultry, perosis must be distinguished from injuries, infectious causes of leg weakness, and deficiencies of choline, biotin, or other nutrients that can affect tendon integrity. Comprehensive diagnostic evaluation including analysis of diet composition and comparison with requirements helps identify manganese as the cause.

Herd-level diagnostics are essential for confirming manganese deficiency and establishing effective prevention programs. Diet analysis to determine actual manganese content and compare with species-specific requirements is fundamental. Feed analysis should include all components of the diet including forages, grains, protein supplements, and mineral mixes. Calculating total dietary manganese intake and comparing with established requirements reveals inadequacies. Analyzing for dietary components that interfere with manganese absorption, particularly calcium, phosphorus, and iron, helps explain deficiency even when total manganese appears adequate. Soil analysis in grazing situations identifies geographic manganese deficiency. Testing water sources for minerals that might affect manganese availability completes the diagnostic picture.

Emergency treatment for manganese deficiency is rarely required given the chronic, progressive nature of the condition, but acute supplementation is warranted when diagnostic testing confirms deficiency in a valuable animal or group. Injectable manganese products can rapidly improve tissue manganese status in individual animals requiring urgent intervention. Manganese sulfate or manganese chloride solutions may be administered intramuscularly or subcutaneously following veterinary guidance on appropriate products and dosages for the species being treated. Animals with severe skeletal deformities or other irreversible changes will not benefit from treatment and may require management decisions regarding culling or euthanasia.

Medical management of manganese deficiency centers on correcting the dietary inadequacy through appropriate supplementation. Oral supplementation is the preferred route for routine management and can be achieved through various methods depending on the production system. Adding manganese sulfate, manganese oxide, or organic manganese sources to the mineral supplement or complete feed provides consistent daily intake. The bioavailability of different manganese sources varies, with organic complexes and chelates generally being more available than oxide forms, though oxide remains economical and effective in most situations. Withdrawal times are not typically a concern with manganese supplementation, as these products are considered nutritional rather than therapeutic, though producers should verify regulatory compliance for their specific products and markets.

Diet reformulation should address not only manganese supply but also factors affecting manganese availability. Reducing excessive calcium supplementation where possible improves manganese absorption, though this must be balanced against calcium requirements for the production stage. Evaluating and potentially reducing iron supplementation or managing high-iron water sources helps remove absorption interference. Adjusting the calcium-to-manganese ratio in the diet to more favorable levels supports improved manganese status. In some cases, changing feed ingredients to those with higher natural manganese content or better manganese availability provides a foundation for adequate nutrition. Working with a qualified animal nutritionist ensures that diet changes address the deficiency without creating other nutritional problems.

Supportive care for animals affected by manganese deficiency focuses on managing the consequences of deficiency while supplementation corrects the underlying problem. Animals with skeletal abnormalities may benefit from housing on soft bedding to reduce stress on affected joints and limbs. Severely affected individuals may need assistance accessing food and water. Growth expectations should be adjusted for animals recovering from deficiency, as catch-up growth may not fully compensate for early setbacks. Breeding animals with impaired reproduction may require an extended recovery period before reproductive function normalizes. Detailed records of supplementation and response help guide ongoing management.

Herd treatment protocols extend beyond individual animal management to address deficiency across the entire at-risk population. Implementing improved supplementation programs for all animals in the group prevents additional cases from developing. In breeding herds, ensuring adequate manganese nutrition for both males and females maximizes the chances of improved reproductive performance. Growing animal groups should receive appropriate supplementation throughout the development period to prevent skeletal problems. Poultry flocks require diet reformulation to ensure adequate manganese for bone development, eggshell formation, and embryonic survival. Monitoring response to supplementation through production parameters and, where practical, tissue testing confirms effectiveness of the intervention.

Treatment decisions must consider the economic realities of livestock production alongside animal welfare concerns. Individual animals with severe, irreversible skeletal deformities may not be candidates for treatment and may need to be culled or euthanized. The cost of extended individual treatment for valuable breeding stock may be justified when the animal's genetic value warrants the investment. Herd-level supplementation costs should be weighed against the production losses from continued deficiency, typically showing favorable economics for adequate supplementation. Long-term prevention through improved mineral programs is more cost-effective than treating clinical deficiency after it develops.

The recovery timeline for manganese deficiency depends heavily on the type and severity of manifestations, with some aspects recovering completely while others remain permanently affected. Biochemical parameters including tissue manganese concentrations begin improving within days to weeks of implementing adequate supplementation, though full restoration of optimal status may require several weeks to months. Reproductive function typically improves over one to several estrous cycles in females once manganese status is corrected, with conception rates gradually returning to normal as the reproductive system recovers. Males may show improved semen quality within the time frame of spermatogenesis, approximately two months in cattle. General condition, growth rate, and feed efficiency improve progressively as metabolic function normalizes.

Post-treatment care and monitoring ensure sustained recovery and help identify any animals failing to respond as expected. Continued provision of adequate dietary manganese through the production cycle prevents recurrence of deficiency. Monitoring growth performance in young animals and reproductive parameters in breeding stock provides objective measures of recovery. Periodic reassessment of diet composition and manganese intake helps verify that the supplementation program remains adequate. Individual animals that showed clinical signs should be observed for any persistent abnormalities that might affect their suitability for production. Documentation of supplementation protocols and responses guides future management decisions.

Prognosis varies dramatically depending on the manifestations present at the time of diagnosis and treatment. Animals with subclinical deficiency affecting only production efficiency have excellent prognoses for complete recovery with appropriate supplementation. Reproductive dysfunction caused by manganese deficiency is generally reversible once adequate nutrition is provided, though conception may require several cycles to normalize. Skeletal abnormalities present at the time of diagnosis will not reverse, and affected animals carry permanent structural defects that may impact their soundness and productivity. Young animals identified early, before significant skeletal changes develop, can avoid these permanent consequences through timely intervention.

Return to production considerations guide management of recovered animals. Breeding animals that have recovered from reproductive manifestations of deficiency can typically return to normal breeding programs once reproductive function has documented improvement. Young animals with mild skeletal changes may still be suitable for market purposes, though severely affected individuals may face price discounts or restricted market options. Poultry with perosis cannot recover normal leg function and typically must be culled. Egg production and quality in laying hens improve following dietary correction, with response often apparent within weeks. Breeding value of animals that experienced deficiency may be affected if the deficiency occurred during critical developmental periods.

Structured supplementation programs form the cornerstone of manganese deficiency prevention, ensuring consistent adequate intake throughout the production cycle. All mineral supplementation programs for farm animals should include manganese at levels appropriate for the species and production stage. Cattle mineral supplements typically provide 2,000 to 3,000 parts per million manganese to ensure adequate intake even with variable consumption rates. Sheep and goat supplements require similar attention to manganese content. Poultry and swine diets are typically complete rations where manganese is included at specified levels during formulation, making feed mill quality control critical for ensuring adequate manganese in every batch.

Biosecurity concepts applied to manganese deficiency prevention involve careful management of all dietary inputs and monitoring of animal status. All feed ingredients including forages, grains, and supplements should be from sources that ensure adequate and consistent manganese content. New feedstuffs should be analyzed for mineral content before incorporation into rations. Animals obtained from outside sources may have different nutritional histories and should be transitioned to the operation's supplementation program. Water sources should be evaluated for mineral content that might affect manganese availability. Maintaining records of feed analyses and supplementation programs creates documentation supporting consistent prevention efforts.

Nutritional prevention extends beyond simple manganese supplementation to comprehensive mineral nutrition management. Balancing the overall mineral profile of the diet ensures that excesses of other minerals do not impair manganese absorption. Calcium supplementation should be limited to levels actually required for the production stage rather than excessive safety margins. Iron content of the diet and water should be evaluated in situations where manganese deficiency has occurred. Providing manganese in forms with good bioavailability ensures that supplemental manganese is actually available to the animal. Working with animal nutritionists to develop balanced rations supports overall health while preventing specific deficiencies.

Management practices supporting manganese adequacy should be integrated into routine farm operations. Regular review and reformulation of mineral and feed programs ensures that supplementation remains appropriate as animal needs change with production stage. Monitoring feed consumption helps identify situations where mineral intake might be reduced due to poor palatability, inadequate feeder access, or other factors. Seasonal adjustments may be needed if forage sources vary in manganese content throughout the year. Ensuring that all animals have adequate access to mineral supplements prevents dominant individuals from monopolizing feeders while subordinate animals become deficient.

Quarantine and testing protocols for manganese focus on identifying at-risk situations and verifying adequacy of prevention programs. Periodic testing of representative animals from herds or flocks helps identify subclinical deficiency before clinical problems develop. New animals entering the operation may warrant assessment of manganese status, particularly if they came from areas or operations with known deficiency problems. Feed testing at regular intervals verifies that formulated manganese levels are actually present in delivered feeds. Soil and forage analysis in grazing operations identifies geographic risk factors that should guide supplementation programs. Documentation of all testing results supports ongoing evaluation of prevention program effectiveness.

Daily management and monitoring for manganese deficiency prevention requires systematic attention to supplementation programs and animal performance parameters. Mineral feeder management including checking consumption, refilling appropriately, and ensuring all animals have access supports consistent manganese intake. Observing animals for subtle signs of deficiency including rough coat, poor growth, and skeletal abnormalities allows early identification of potential problems. Monitoring reproductive performance through breeding records helps identify declining fertility that might indicate mineral deficiency. In poultry operations, tracking growth rates, leg health, egg production, and shell quality provides early warning of potential manganese inadequacy. Feed bunk management ensuring proper diet delivery and consumption contributes to reliable nutrient intake.

Housing and environmental management influences manganese nutrition through effects on feed intake and mineral availability. Comfortable housing that encourages good feed consumption supports adequate mineral intake. Adequate feeder space ensures that all animals, including subordinate individuals, can access mineral supplements without excessive competition. Water system management prevents mineral accumulation in lines that might affect manganese availability. Ventilation and temperature control reduce heat stress that can depress feed intake and mineral consumption. Bedding management in confined housing prevents manure buildup that might affect animal comfort and feed intake.

Herd health programs should incorporate manganese status monitoring as a component of comprehensive nutritional management. Annual or semi-annual review of mineral supplementation programs with veterinary or nutritionist input ensures ongoing adequacy. Diagnostic testing for manganese status during routine health management visits provides data for program evaluation. Incorporating manganese evaluation into investigation of reproductive problems or growth issues helps identify this deficiency when it contributes to clinical problems. Coordinating manganese management with other trace mineral programs ensures balanced nutrition without excessive supplementation of any single element. Record keeping linking supplementation programs with production outcomes demonstrates program effectiveness.

Record keeping and monitoring create the foundation for effective manganese deficiency prevention over time. Documenting feed and mineral supplement analyses with dates and sources allows verification of consistent manganese supply. Recording animal performance parameters including growth rates, reproductive outcomes, and health events provides data for identifying potential deficiency. Tracking any confirmed or suspected manganese deficiency cases helps identify patterns and risk factors specific to the operation. Maintaining supplier records for feeds and supplements supports quality control and problem investigation if deficiency occurs. Creating summary reports comparing supplementation programs with production outcomes guides program refinement.

Economic considerations for manganese deficiency prevention strongly favor consistent supplementation programs. The cost of adequate manganese supplementation is minimal compared to the production losses from deficiency. Calculating the value of improved reproduction, better growth performance, and reduced leg problems demonstrates favorable return on supplement investment. Comparing costs of prevention with costs of treating clinical deficiency or culling affected animals reinforces the economic case for prevention. Considering the indirect costs of deficiency including veterinary fees, diagnostic testing, and management time strengthens the economic analysis. Long-term budgeting should include adequate mineral supplementation as a non-negotiable production expense.

Breed-specific susceptibility to manganese deficiency is not well-documented in cattle, with risk determined more by production system and dietary management than by genetic background. All cattle breeds can develop manganese deficiency when dietary supply is inadequate, and no breed has demonstrated clear resistance or heightened susceptibility. Dairy cattle in high-production systems face increased risk due to elevated metabolic demands and diets that may be high in calcium, which interferes with manganese absorption. Beef cattle in extensive grazing systems on manganese-poor soils face geographic risk regardless of breed. Rapidly growing feedlot cattle of any breed have high manganese requirements that may not be met by standard feeding programs. Young, growing animals of all breeds are most susceptible to the skeletal manifestations of deficiency.

Production type and system significantly influence manganese deficiency risk across all farm animal species. High-producing dairy cattle have elevated requirements and face absorption interference from high-calcium diets designed for milk production. Beef cattle on grazing systems depend on forage manganese content, which varies by soil type and geographic location. Feedlot cattle receiving high-grain diets may have inadequate manganese intake from feed alone. Breeding animals of all species have elevated requirements that must be met for optimal reproduction. In poultry, commercial broilers selected for rapid growth and meat chickens in general face high skeletal demands for manganese. Laying hens require manganese for eggshell formation and embryonic development. Turkey production involves birds with high growth rates and significant manganese requirements.

Genetic selection related to manganese status focuses primarily on indirect approaches rather than direct selection for manganese metabolism. Selection for production traits that increase metabolic demands, such as milk production, growth rate, or reproductive output, indirectly increases manganese requirements and may heighten deficiency risk in populations selected for maximum performance. No specific genetic tests for manganese metabolism or deficiency susceptibility are available for routine use in farm animals. Breed associations and genetic improvement programs do not typically include manganese-related traits in selection indices. Practical approaches to managing genetic aspects of manganese nutrition focus on ensuring that supplementation programs meet the requirements of genetically superior animals with high production demands.

Commonly co-occurring conditions with manganese deficiency include other trace mineral deficiencies that share similar causes or risk factors. Zinc deficiency may occur alongside manganese deficiency in animals consuming diets inadequate in multiple trace minerals or high in antagonists like calcium. Copper deficiency shares some geographic risk factors with manganese deficiency and produces some similar clinical signs including poor growth and reproductive failure. Iron deficiency is less common but may occur in situations of general mineral inadequacy. Combined trace mineral deficiency creates more severe clinical presentations and more challenging diagnostic situations. Vitamin deficiencies, particularly vitamin D in housed animals, may compound skeletal problems associated with manganese deficiency.

Conditions with similar clinical presentations that must be distinguished from manganese deficiency span multiple organ systems. Skeletal abnormalities resembling manganese deficiency can result from copper deficiency, which causes characteristic long bone changes, or zinc deficiency, which affects cartilage development. Vitamin D deficiency produces rickets with enlarged joints and skeletal deformities. Genetic conditions affecting bone and cartilage development may mimic nutritional deficiency. Infectious causes of lameness and joint swelling must be ruled out in young animals with skeletal abnormalities. Reproductive failure has numerous differential diagnoses including infectious diseases, other nutritional deficiencies, and management factors. In poultry, perosis must be distinguished from choline deficiency, biotin deficiency, and various infectious causes of leg weakness.

Complications and sequelae of manganese deficiency primarily relate to the irreversible nature of skeletal deformities once they develop. Animals with skeletal abnormalities face lifelong soundness issues that may affect their productivity and welfare. Secondary joint problems including arthritis may develop in affected limbs. Reproductive consequences of deficiency during critical developmental periods may have lasting effects on fertility. Growth and development setbacks during deficiency may not be fully compensated even after dietary correction. Carryover effects on offspring from deficient dams include reduced vitality and potential congenital abnormalities. Comprehensive management of manganese deficiency must address both immediate treatment needs and long-term management of animals with permanent consequences.